We also demonstrate that the anti-tumor activity of HSA/TIMP-2 is strongly associated with anti-angiogenesis attributed to a reduction of MMP-2 production but without inhibition of MT1-MMP, indicating that HSA/TIMP-2 plays a more complex role in anti-angiogenesis. This evidence concerns the gene TIMP2 and neoplasm.